No takes yet. Share an insight, caveat, or question.
Experimental and clinical evidence links COX2 to esophageal cancer progression, indicating potential for therapy.
Naoki Hashimoto (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: